Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Locally Advanced Rectal Cancer × Capecitabine × Clear all

Phase

Phase 2 15 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 104 Colorectal Neoplasms 63 Stomach Neoplasms 49 Rectal Neoplasms 42 Colonic Neoplasms 24 Neoplasm Metastasis 21 Triple Negative Breast Neoplasms 18 Nasopharyngeal Carcinoma 18 Pancreatic Neoplasms 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Neoplasms 12 Gallbladder Neoplasms 7 Cholangiocarcinoma 7 Adenocarcinoma 6 Esophageal Neoplasms 5 Adenocarcinoma Of Esophagus 5 Esophageal Squamous Cell Carcinoma 4 Neuroendocrine Tumors 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Recurrence 2 Pathologic Complete Response 2 Liver Neoplasms 2 Intestinal Neoplasms 2 Hand-Foot Syndrome 2 HER2-positive Advanced Breast Cancer 2 HER2 Positive Metastatic Breast Cancer 2 Drug-Related Side Effects and Adverse Reactions 2

Interventions

Radiation 1 Oxaliplatin 1 Irinotecan 1 Folfox protocol 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02605265 2025-08-28

CinClare

Fudan University

Phase 3 Completed

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡